Clinical Trial: Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Sponsor and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)

Contact
Contact: Peter R. Watson, MD
252-559-2200ext.201

Principal Investigator
Study Chair: Sherif S. Farag, MD, PhD

ClinicalTrials.gov Identifier
NCT00896701